Albumin Paclitaxel Combined with Intrapleural Infusion of Bevacizumab + Lobaplatin for the Second-Line Treatment of Patients with Non-Squamous Non-Small Cell Lung Cancer

<div>Pathological image. (a)–(c), before treatment. (a) Image of pleural effusion under the microscope; (b) hemorrhagic MPE; (c) turbid amber MPE; (d) image of pleural effusion under microscope of patients with effective treatment; (e) MPE (color tends to clear) in a patient with effective treatment.</div>

Journal of Oncology

fig1

Figure 1

Figure 1: Albumin Paclitaxel Combined with Intrapleural Infusion of Bevacizumab + Lobaplatin for the Second-Line Treatment of Patients with Non-Squamous Non-Small Cell Lung Cancer 

Figure 1 | Albumin Paclitaxel Combined with Intrapleural Infusion of Bevacizumab + Lobaplatin for the Second-Line Treatment of Patients with Non-Squamous Non-Small Cell Lung Cancer 